Publication | Open Access
Bronchoalveolar lavage cell pattern from healthy human lung
97
Citations
28
References
2011
Year
AsthmaAcute Lung InjuryClinical ImmunologyInflammatory Lung DiseaseHealthy Human LungLung InflammationHealthy SubjectsImmunodeficienciesLaboratory ImmunologyImmunologyImmune RegulationPathologyPulmonary Alveolar ProteinosisBronchoalveolar LavageImmune SystemImmune DysregulationImmunopathologyTracheobronchitisImmune SurveillanceAutoimmunityPulmonary MedicineImmune FunctionLung CancerImmune Cell DevelopmentMedicineDifferential Cell CountsImmunological Biomarkers
Bronchoalveolar lavage (BAL) is widely accepted as a key diagnostic procedure in interstitial lung diseases (ILD). We performed a study to obtain reference intervals of differential cell patterns in BAL fluid with special attention to the origin of lavage fluid, e.g. bronchial/alveolar, to atopy and smoking status and to age of the healthy people. We performed bronchoalveolar lavage in 55 healthy subjects with known atopy status (age: 18-64 years, non-smokers/smokers: 34/21) and determined differential cell counts and lymphocyte subsets in BAL fluid and blood. Moreover, in a subgroup of non-smoking healthy individuals we measured the expression of the regulatory T cell marker forkhead box protein 3 (FoxP3) on blood and BAL fluid lymphocytes in addition to a comprehensive set of activation markers. Differential cell counts from the alveolar lavage fraction differed significantly from calculated pooled fractions (n = 11). In contrast, marginal differences were found between atopic and non-atopic subjects. Interestingly, the BAL fluid CD4(+) /CD8(+) ratio correlated strongly with age (r(2) = 0·50, P < 0·0001). We consider the bronchial and alveolar fraction to be lavage fluid from fundamentally different compartments and recommend analysis of the alveolar fraction in diagnostic work-up of ILD. In addition, our data suggest that age corrected BAL fluid CD4(+) /CD8(+) ratios should be used in the clinical evaluation of patients with interstitial lung diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1